You are leaving ENJUVIA.com Web site. Links to other sites are provided as a convenience to the viewer. Duramed accepts no responsibility for the content of linked sites.
Duramed Pharmaceuticals, Inc. ("Duramed") respects your privacy, and the privacy of all visitors to its Web sites (the "sites"). It is the company's policy to collect only personally identifiable information, such as names, addresses, telephone/fax numbers, or e-mail addresses, when such information is voluntarily submitted by our visitors. This information will be kept strictly confidential and will not be sold, reused, rented, loaned, or otherwise disclosed, except as described in this Privacy Policy.
We will not disclose your information other than to our affiliates or contractors, where necessary, to operate and maintain this Web site or as required by law or legal process.
We will only use the information we collect from you to answer any of your requests for information, such as to send you updates or other informational mailings you may find useful, or to better understand your needs.
Tracking Technology ("Cookies")
Cookies are small text files that are sent by a Web site, accepted by a Web browser, and then placed on your hard drive. Duramed Web sites may use cookies to collect data that help provide information regarding the functionality of the site or to help analyze browsing patterns and use of the site.
Children
The sites are not intended or designed to attract children under the age of 18. Duramed does not collect personally identifiable data from any person we know to be under the age of 18.
Revisions to This Policy
Duramed reserves the right, at our discretion, to change, modify, add, or remove portions of this policy at any time. If we change our Privacy Policy, we will post those changes on this page so that you may become aware of what information we may collect, how we may use it, and under what circumstances we may disclose it. You should visit this page from time to time to review the then-current policy because it is binding on you. This Privacy Policy was last updated June 2003.
General
Links from these sites may take you to sites not covered by this Privacy Policy, and we advise you to check the applicable privacy practices yourself.
This site makes use of the latest version of the Macromedia Flash Player. Download the player now!
The requested information is provided in Portable Document Format (PDF). To view and print this document, you'll need to install a copy of the free Adobe® Reader®. If you already have Adobe Reader installed, click "VIEW PDF" below. If you need Adobe Reader, you can download it from the Adobe Reader Download page.
Hot flashes and night sweats are the most common symptoms of menopause. Nearly three out of four women have hot flashes during menopause. Some hot flashes are easily tolerated, while others range from embarrassing to debilitating.
Vaginal dryness and pain with sex, symptoms of vaginal atrophy associated with menopause, are also common. In fact, as many as 40% of postmenopausal women have symptoms related to vaginal atrophy.
ENJUVIA is an FDA-approved oral estrogen therapy that has been shown to provide relief of moderate-to-severe menopausal hot flashes, night sweats, vaginal dryness, and pain with sex, which are symptoms associated with menopause. It is a plant-derived formulation of 10 synthetic estrogens.*
The unique ENJUVIA delivery system provides slow release of estrogens over several hours. This is made possible through Surelease®† technology, combined with a cellulose-based polymer tablet design.
The following illustration shows how the ENJUVIA delivery system works:
If you have any questions, be sure to speak with your healthcare professional. He or she can best determine if ENJUVIA is right for you.
Important information you should know when taking estrogens like ENJUVIA™:
ENJUVIA is a medicine that contains estrogen hormones. It is prescribed for relief of moderate-to-severe hot flashes and night sweats, and moderate-to-severe vaginal dryness and pain with intercourse, symptoms associated with menopause.
Estrogens increase the risk for cancer of the uterus (womb). If you experience persistent or recurring vaginal bleeding while taking estrogens let your doctor know right away, as this could be a warning sign for cancer. Your doctor should check for the cause of any unusual vaginal bleeding after menopause. Estrogens (alone, or in combination with progestins) should not be used to prevent heart disease, heart attacks, strokes, or dementia.
Estrogens (alone or in combination with progestins) may increase the risk of heart attack, stroke, blood clots, and breast cancer. Estrogens (alone or in combination with progestins) may increase your risk of dementia, based on a study of women age 65 or older. Because of these risks, estrogens should be used at the lowest dose for the shortest period of time. You and your doctor should talk regularly to determine whether you still need treatment with ENJUVIA.
Who should not use ENJUVIA?
Do not use ENJUVIA if you:
What are the common side effects with ENJUVIA?
You may experience headache, breast pain, irregular vaginal bleeding or spotting, stomach/abdominal cramps and bloating, nausea and vomiting, or hair loss.
Please see Patient Information section of the prescribing information.
Prescribing Information | Important Safety Information | Contact Us | Privacy Policy | Site Map
The information on this site is intended for US residents only.
© 2008 Duramed Pharmaceuticals, Inc.
ENJUVIA™ is a trademark, and Duramed® is a registered trademark, of Duramed Pharmaceuticals, Inc.
